Back to Search

NICOLE HYNES, MD

MD

Rheumatology Physician

NPI: 1750415063Individual

Specialties, Licenses & Credentials

Student in an Organized Health Care Education/Training Program

Student in an Organized Health Care Education/Training Program

Code: 390200000X

0600002821(VT)
Rheumatology PhysicianPrimary

Internal Medicine — Rheumatology

Code: 207RR0500X

0420011649(VT)

Research & Publications (20)

The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
PMID 19584287·Cancer Res·2009
7-preclinical
Memo is a cofilin-interacting protein that influences PLCgamma1 and cofilin activities, and is essential for maintaining directionality during ErbB2-induced tumor-cell migration.
PMID 19223396·J Cell Sci·2009
8-other
Testosterone: from initiating change to modulating social organisation in domestic fowl (Gallus gallus domesticus).
PMID 19337720·Naturwissenschaften·2009
7-preclinical
WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth.
PMID 19473496·Breast Cancer Res·2009
7-preclinical
Wnt3a regulates proliferation and migration of HUVEC via canonical and non-canonical Wnt signaling pathways.
PMID 19523451·Biochem Biophys Res Commun·2009
8-other
PI3K inhibition overcomes trastuzumab resistance: blockade of ErbB2/ErbB3 is not always enough.
PMID 19411062·Cancer Cell·2009
7-preclinical
ErbB receptors and signaling pathways in cancer.
PMID 19208461·Curr Opin Cell Biol·2009
6-review
ERBB1 and ERBB2 have distinct functions in tumor cell invasion and intravasation.
PMID 19458057·Clin Cancer Res·2009
7-preclinical
Five-year Irish trial of CLI patients with TASC II type C/D lesions undergoing subintimal angioplasty or bypass surgery based on plaque echolucency.
PMID 19642779·J Endovasc Ther·2009
4-observational
Inhibition of multiple vascular endothelial growth factor receptors (VEGFR) blocks lymph node metastases but inhibition of VEGFR-2 is sufficient to sensitize tumor cells to platinum-based chemotherapeutics.
PMID 18316624·Cancer Res·2008
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.

Contact & Hours

Address
111 COLCHESTER AVE, EP5
BURLINGTON, VT 05401

Quick Facts

NPI
1750415063
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
2
Locations
1
Publications
20

Are you this provider?

Claim Your Profile